A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity

Lignende værker

• Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy
  af: Palmer, Adam C., et al.
  Udgivet: (2017)
• Scaling drug indication curation through crowdsourcing
  af: Khare, Ritu, et al.
  Udgivet: (2015)
• Blended Vision Achieved by Combining High and Low Addition Power Diffractive Intraocular Lenses with Micromonovision: A Clinical Outcome
  af: Ouchi, Masayuki, et al.
  Udgivet: (2020)
• Quantification of drug-induced fractional killing using high-throughput microscopy
  af: Inde, Zintis, et al.
  Udgivet: (2021)
• Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
  af: Meletiadis, Joseph, et al.
  Udgivet: (2010)